{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:19:11Z","timestamp":1785410351099,"version":"3.56.0"},"reference-count":43,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Fail Rev"],"abstract":"<jats:p>Patients with chronic kidney disease and\/or cardiovascular disease are at heightened risk of developing hyperkalaemia. This electrolyte disorder is prevalent and, if left untreated, typically results in fatal outcomes. The implementation of standardised, specialised management strategies represents a valuable tool for clinicians in the care of these patients. The primary objective of this study is to present a consensus document for the management of hyperkalaemia of cardiorenal origin, developed by a group of experts in cardiology and nephrology, opinion leaders in Mexico. To this end, a Delphi panel was formed, comprising a group of cardiologists and a group of nephrologists, each coordinated by a leader who concentrated the information. The panellists responded to a questionnaire that was sent to them. In a virtual meeting, the responses were reviewed and a consensus was reached by all participants based on the current literature.<\/jats:p>","DOI":"10.15420\/cfr.2025.03","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:19:10Z","timestamp":1777375150000},"source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Management of Hyperkalaemia in Patients with Chronic Kidney Disease and Cardiovascular Conditions: Expert Recommendations from Mexico"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-4581","authenticated-orcid":false,"given":"Antonio","family":"M\u00e9ndez-Dur\u00e1n","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xddgg98","id-type":"ROR","asserted-by":"publisher"}],"name":"Mexican Social Security Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8800-7298","authenticated-orcid":false,"given":"Juan B","family":"Ivey-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1339-9683","authenticated-orcid":false,"given":"Genaro H","family":"Mendoza-Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0593-2571","authenticated-orcid":false,"given":"Amada","family":"\u00c1lvarez-Sangabriel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046e90j34","id-type":"ROR","asserted-by":"publisher"}],"name":"Instituto Nacional de Cardiolog\u00eda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C","family":"S\u00e1nchez-Guerrero","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/016b66y19","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Christus Muguerza Alta Especialidad"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D","family":"D\u00edaz-Garc\u00eda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02a2kzf50","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Cl\u00ednic de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n A","family":"Borges-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E","family":"Morales-Buenrostro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00xgvev73","id-type":"ROR","asserted-by":"publisher"}],"name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateo","family":"Quilant\u00e1n-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-1175","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Ru\u00edz-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A","family":"Ch\u00e1vez-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Clegg DJ, Headley SA, Germain MJ. Impact of dietary potassium restrictions in CKD on clinical outcomes: benefits of a plant-based diet. Kidney Med 2020;2:476\u201387. https:\/\/doi.org\/10.1016\/j.xkme.2020.04.007; PMID:\u00a032775988.","DOI":"10.1016\/j.xkme.2020.04.007"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Babich JS, Kalantar-Zadeh K, Joshi S. Taking the kale out of hyperkalemia: plant foods and serum potassium in patients with kidney disease. J Ren Nutr 2022;32:641\u20139. https:\/\/doi.org\/10.1053\/j.jrn.2022.01.013; PMID:\u00a035131414.","DOI":"10.1053\/j.jrn.2022.01.013"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mathialahan T, Maclennan KA, Sandle LN, et al. Enhanced large intestinal potassium permeability in end-stage renal disease. J Pathol 2005;206:46\u201351. https:\/\/doi.org\/10.1002\/path.1750; PMID:\u00a015772943.","DOI":"10.1002\/path.1750"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"de Sequera P, Buades JM, Reyes-Alc\u00e1zar V, et al. Impact of pruriture associated with chronic renal disease (PaCKD) on the quality of life of patients in hemodialysis in Spain. Nefrolog\u00eda 2023;43:663\u20137. https:\/\/doi.org\/10.1016\/j.nefroe.2023.12.004; PMID:\u00a038182446.","DOI":"10.1016\/j.nefroe.2023.12.004"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Eriguchi R, Obi Y, Soohoo M, et al. Racial and ethnic differences in mortality associated with serum potassium in incident peritoneal dialysis patients. Am J Nephrol 2019;50:361\u20139. https:\/\/doi.org\/10.1159\/000502998; PMID:\u00a031522173.","DOI":"10.1159\/000502998"},{"key":"ref5","unstructured":"Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2020;97:42\u201361. https:\/\/doi.org\/10.1016\/j.kint.2019.09.018; PMID:\u00a031706619."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Belmar Vega L, Galabia ER, Bada da Silva J, et al. Epidemiology of hyperkalemia in chronic kidney disease. Nefrologia (Engl Ed) 2019;39:277\u201386. https:\/\/doi.org\/10.1016\/j.nefro.2018.11.011; PMID:\u00a030898450.","DOI":"10.1016\/j.nefroe.2018.11.014"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Lariv\u00e9e NL, Michaud JB, More KM, et al. Hyperkalemia: prevalence, predictors and emerging treatments. Cardiol Ther 2023;12:35\u201363. https:\/\/doi.org\/10.1007\/s40119-022-00289-z; PMID:\u00a036503972.","DOI":"10.1007\/s40119-022-00289-z"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Palmer BF, Clegg DJ. Hyperkalemia treatment standard. Nephrol Dial Transplant 2024;39:1097\u2013104. https:\/\/doi.org\/10.1093\/ndt\/gfae056; PMID:\u00a038425037.","DOI":"10.1093\/ndt\/gfae056"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lindner G, Burdmann EA, Clase CM, et al. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. Eur J Emerg Med 2020;27:329\u201337. https:\/\/doi.org\/10.1097\/MEJ.0000000000000691; PMID:\u00a032852924.","DOI":"10.1097\/MEJ.0000000000000691"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"AlSahow A, AbdulShafy M, Al-Ghamdi S, et al. Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC). J Clin Hypertens (Greenwich) 2023;25:251\u20138. https:\/\/doi.org\/10.1111\/jch.14633; PMID:\u00a036715554.","DOI":"10.1111\/jch.14633"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Costa D, Patella G, Provenzano M, et al. Hyperkalemia in CKD: an overview of available therapeutic strategies. Front Med (Lausanne) 2023;10:1178140. https:\/\/doi.org\/10.3389\/fmed.2023.1178140; PMID:\u00a037583425.","DOI":"10.3389\/fmed.2023.1178140"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Leite M, Sampaio F, Saraiva FA, et al. The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta-analysis. ESC Heart Fail 2023;10:1822\u201334. https:\/\/doi.org\/10.1002\/ehf2.14284; PMID:\u00a036896801.","DOI":"10.1002\/ehf2.14284"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Almenar Bonet L, Gonz\u00e1lez-Franco \u00c1, Working Group for the Study of Hyperkalemia. Consensus on the management of hyperkalemia in patients with heart failure: recommendations from the SEC-SEMI. Rev Clin Esp (Barc) 2022;222:235\u201340. https:\/\/doi.org\/10.1016\/j.rceng.2020.11.012; PMID:\u00a034348884.","DOI":"10.1016\/j.rceng.2020.11.012"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Crespo-Leiro MG, Barge-Caballero E, Segovia-Cubero J, et al. Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry. Rev Esp Cardiol (Engl Ed) 2020;73:313\u201323. https:\/\/doi.org\/10.1016\/j.rec.2019.05.015; PMID:\u00a031672562.","DOI":"10.1016\/j.rec.2019.09.006"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes. Am J Nephrol 2017;46:213\u201321. https:\/\/doi.org\/10.1159\/000479802.","DOI":"10.1159\/000479802"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Toto F, Salvioni E, Magr\u00ed D, et al. Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base. Int J Cardiol 2023;371:273\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2022.09.030; PMID:\u00a036115445.","DOI":"10.1016\/j.ijcard.2022.09.030"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Saldarriaga C, de Gracia SSG, Mejia MIP, et al. Diagnostic and therapeutic practice for heart failure with preserved ejection fraction around the world: an international survey. Curr Probl Cardiol 2024;49:102799. https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102799; PMID:\u00a039214158.","DOI":"10.1016\/j.cpcardiol.2024.102799"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Tromp J, Ouwerkerk W, van Veldhuisen DJ, et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC Heart Fail 2022;10:73\u201384. https:\/\/doi.org\/10.1016\/j.jchf.2021.09.004; PMID:\u00a034895860.","DOI":"10.1016\/j.jchf.2021.09.004"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Emektar E. Acute hyperkalemia in adults. Turk J Emerg Med 2023;23:75\u201381. https:\/\/doi.org\/10.4103\/tjem.tjem_288_22; PMID:\u00a037169032.","DOI":"10.4103\/tjem.tjem_288_22"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Humphrey T, Davids MR, Chothia MY, et al. How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies. Clin Kidney J 2022;15:727\u201337. https:\/\/doi.org\/10.1093\/ckj\/sfab243; PMID:\u00a035371465.","DOI":"10.1093\/ckj\/sfab243"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Sofue T, Nakagawa N, Kanda E, et al. Prevalence of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLOS One 2020;15:e0240402. https:\/\/doi.org\/10.1371\/journal.pone.0240402; PMID:\u00a033057377.","DOI":"10.1371\/journal.pone.0240402"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 2015;372:211\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1410853; PMID:\u00a025415805.","DOI":"10.1056\/NEJMoa1410853"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez DA, D\u00edaz Garc\u00eda JD, S\u00e1nchez IR, et al. Hyperkalemia in patients with chronic kidney disease managed with and without dialysis. Int J Nephrol Kidney Fail 2024;10:1-6. https:\/\/doi.org\/10.16966\/2380-5498.247.","DOI":"10.16966\/2380-5498.247"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Maggioni AP, Dondi L, Andreotti F, et al. Prevalence, clinical impact and costs of hyperkalaemia: special focus on heart failure. Eur J Clin Invest 2021;51:e13551. https:\/\/doi.org\/10.1111\/eci.13551; PMID:\u00a033786826.","DOI":"10.1111\/eci.13551"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Burton JO, Coats AJ, Kovesdy CP, et al. An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum. Eur J Heart Fail 2022;24:1467\u201377. https:\/\/doi.org\/10.1002\/ejhf.2612; PMID:\u00a035791065.","DOI":"10.1002\/ejhf.2612"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kovesdy CP, Matsushita K, Sang Y, et al. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. Eur Heart J 2018;1:1535\u201342.","DOI":"10.1093\/eurheartj\/ehy100"},{"key":"ref27","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368; PMID:\u00a034447992."},{"key":"ref28","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney\u00a0disease. Kidney Int 2021;99:S1\u2013S87. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003; PMID:\u00a033637192."},{"key":"ref29","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 2022;102:S1\u2013127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008; PMID:\u00a036272764."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Rosano GM, Tamargo J, Kjeldsen KP, et al. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J Cardiovasc Pharmacother 2018;4:180\u20138. https:\/\/doi.org\/10.1093\/ehjcvp\/pvy015; PMID:\u00a029726985.","DOI":"10.1093\/ehjcvp\/pvy015"},{"key":"ref31","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022;79:e263\u2013421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012; PMID:\u00a035379503."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Morze J, Danielewicz A, Hoffmann G, Schwingshackl L. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: a second update of a systematic review and meta-analysis of cohort studies. J Acad Nutr Diet 2020;120:1998\u20132031. https:\/\/doi.org\/10.1016\/j.jand.2020.08.076; PMID:\u00a033067162.","DOI":"10.1016\/j.jand.2020.08.076"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-\u00c1lvarez JR. La dieta mediterr\u00e1nea, una herramienta esencial para la promoci\u00f3n de la salud. Enferm Nefrol 2023;26:103\u20134. https:\/\/doi.org\/10.37551\/S2254-28842023010.","DOI":"10.37551\/S2254-28842023010"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr 2020;11:1150\u201360. https:\/\/doi.org\/10.1093\/advances\/nmaa041; PMID:\u00a032330233.","DOI":"10.1093\/advances\/nmaa041"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Palmer BF, Clegg DJ. Hyperkalemia across the continuum of kidney function. Clin J Am Soc Nephrol 2018;13:155\u20137. https:\/\/doi.org\/10.2215\/CJN.09340817; PMID:\u00a029114006.","DOI":"10.2215\/CJN.09340817"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Beard MM, McKenzie JJ, Potter TG, Varney Gill K. Evaluating risk factors for developing hypoglycemia during treatment of hyperkalemia with intravenous regular insulin. J Pharm Pract 2024;37:1091\u20138. https:\/\/doi.org\/10.1177\/08971900231223025; PMID:\u00a038178363.","DOI":"10.1177\/08971900231223025"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation 2022;145:1460\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057736; PMID:\u00a035394821.","DOI":"10.1161\/CIRCULATIONAHA.121.057736"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Liou HH, Chiang SS, Wu SC, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 1994;23:266\u201371. https:\/\/doi.org\/10.1016\/s0272-6386(12)80983-8; PMID:\u00a08311086.","DOI":"10.1016\/S0272-6386(12)80983-8"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Batterink J, Cessford TA, Taylor RA. Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev 2015;10:CD010344. https:\/\/doi.org\/10.1002\/14651858.CD010344.pub2; PMID:\u00a035658162.","DOI":"10.1002\/14651858.CD010344.pub2"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Di Palo KE, Sinnett MJ, Goriacko P. Assessment of patiromer monotherapy for hyperkalemia in an acute care setting. JAMA Netw Open 2022;5:e2145236. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.45236; PMID:\u00a035080601.","DOI":"10.1001\/jamanetworkopen.2021.45236"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Xu Y, Fu EL, Trevisan BM, Jernberg T, et al. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. Am Heart J 2022;243:177\u201386. https:\/\/doi.org\/10.1016\/j.ahj.2021.09.014; PMID:\u00a034610282.","DOI":"10.1016\/j.ahj.2021.09.014"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"De Nicola L, Ferraro PM, Montagnani A, et al. Recommendations for the management of hyperkalemia in receiving renin-angiotensin-aldosterone system inhibitors. Intern Emerg Med 2024;19:295\u2013306. https:\/\/doi.org\/10.1007\/s11739-023-03427-0; PMID:\u00a037775712.","DOI":"10.1007\/s11739-023-03427-0"}],"container-title":["Cardiac Failure Review"],"original-title":[],"link":[{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:19:35Z","timestamp":1777375175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":43,"URL":"https:\/\/doi.org\/10.15420\/cfr.2025.03","relation":{},"ISSN":["2057-7540","2057-7559"],"issn-type":[{"value":"2057-7540","type":"print"},{"value":"2057-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"e10"}}